PPP

PAR DRUGS AND CHEM LTD

No trades
See on Supercharts
Market capitalization
‪3.34 B‬INR
‪113.34 M‬INR
‪950.98 M‬INR
Beta (1Y)
−0.50

About PAR DRUGS AND CHEM LTD

Headquarters
Vadodara
Employees (FY)
105
Founded
1982
ISIN
INE04LG01015
FIGI
BBG00P33NGL0
Par Drugs & Chemicals Ltd. engages in the business of manufacturing active pharma ingredients and fine chemicals for domestic market as well as for exports to international markets. The firm also offers magnesium hydroxide, sucralfate, and trisilicate. The company was founded by Vallabhbhai Jivabhai Savani in 1982 and is headquartered in Vadodara, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PAR is 278.60 INR — it has increased by 2.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange PAR DRUGS AND CHEM LTD stocks are traded under the ticker PAR.
PAR stock is 22.18% volatile and has beta coefficient of −0.50. Check out the list of the most volatile stocks — is PAR DRUGS AND CHEM LTD there?
Yes, you can track PAR DRUGS AND CHEM LTD financials in yearly and quarterly reports right on TradingView.
PAR stock has risen by 13.09% compared to the previous week, the month change is a 35.14% rise, over the last year PAR DRUGS AND CHEM LTD has showed a 68.95% increase.
PAR net income for the last quarter is ‪34.22 M‬ INR, while the quarter before that showed ‪48.92 M‬ INR of net income which accounts for −30.04% change. Track more PAR DRUGS AND CHEM LTD financial stats to get the full picture.
PAR DRUGS AND CHEM LTD dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0.78% and 16.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PAR DRUGS AND CHEM LTD stock right from TradingView charts — choose your broker and connect to your account.
PAR reached its all-time high on Oct 12, 2021 with the price of 310.60 INR, and its all-time low was 13.75 INR and was reached on Mar 30, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 105.00 employees. See our rating of the largest employees — is PAR DRUGS AND CHEM LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PAR DRUGS AND CHEM LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PAR DRUGS AND CHEM LTD stock shows the strong buy signal. See more of PAR DRUGS AND CHEM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PAR DRUGS AND CHEM LTD EBITDA is ‪221.07 M‬ INR, and current EBITDA margin is 18.69%. See more stats in PAR DRUGS AND CHEM LTD financial statements.